14/09/2026Published by Fondazione Gianni Bonadonna at 14/09/2026Categories Events UncategorizedDaraxonrasib in metastatic pancreatic cancer
07/09/2026Published by Fondazione Gianni Bonadonna at 07/09/2026Categories Events UncategorizedRelacorilant plus nab-paclitaxel in platinum-resistant ovarian cancer
31/08/2026Published by Fondazione Gianni Bonadonna at 31/08/2026Categories Events UncategorizedCibisatamab and FAP-4-1BBL in microsatellite-stable metastatic colorectal cancer
24/08/2026Published by Fondazione Gianni Bonadonna at 24/08/2026Categories Events UncategorizedPembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer
03/08/2026Published by Fondazione Gianni Bonadonna at 03/08/2026Categories Events UncategorizedNivolumab plus ipilimumab as first-line therapy of advanced renal cell carcinoma
27/07/2026Published by Fondazione Gianni Bonadonna at 27/07/2026Categories Events UncategorizedA new successful pre-transplant strategy without chemo or radiotherapy
20/07/2026Published by Fondazione Gianni Bonadonna at 20/07/2026Categories Events UncategorizedSacituzumab govitecan plus pembrolizumab in triple-negative breast cancer
13/07/2026Published by Fondazione Gianni Bonadonna at 13/07/2026Categories Events UncategorizedAdjuvant nivolumab plus relatlimab in stage III/IV melanoma
06/07/2026Published by Fondazione Gianni Bonadonna at 06/07/2026Categories Events UncategorizedRepotrectinib in NTRK fusion-positive advanced solid tumors
